Leslie J. Klaff

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity

Louis J. Aronne, Naveed Sattar, Deborah B. Horn et al. · JAMA · 2023 · 709 citations · Full text

Agriculture, Pharmacotherapy, Clinical Pharmacology +16

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System

Timothy S. Bailey, Bruce W. Bode, Mark P. Christiansen et al. · Diabetes Technology & Therapeutics · 2015 · 680 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

Thomas R. Pieber, Bruce W. Bode, Young Min Cho et al. · The Lancet Diabetes & Endocrinology · 2019 · 274 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

P. Raskin, Leslie J. Klaff, Richard M. Bergenstal et al. · Diabetes Care · 2000 · 251 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes

Julio Rosenstock, Leslie J. Klaff, Sherwyn Schwartz et al. · Diabetes Care · 2010 · 226 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17